Information Provided By:
Fly News Breaks for February 26, 2020
CME
Feb 26, 2020 | 06:02 EDT
UBS analyst Alex Kramm upgraded CME Group to Buy from Neutral with a price target of $233, up from $214. Heightened levels of volume and volatility are driving near-term estimates higher, while the stock's current valuation does not yet reflect a more uncertain environment, Kramm tells investors in a research note. The analyst is now 4% and 6% above consensus for fiscal 2020 and 2021, respectively, and he expects Street estimates "to come up as strong volume trends become more appreciated."
News For CME From the Last 2 Days
There are no results for your query CME